HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pyle, L. E. Articles by Fidge, N. Search for Related Content PubMed PubMed Citation Articles by Pyle, L. E. Articles by Fidge, N. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 2355-2361, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Secretion of biologically active human proapolipoprotein A-I in a baculovirus-insect cell system: protection from degradation by protease inhibitors

LE Pyle, P Barton, Y Fujiwara, A Mitchell and N Fidge
Baker Medical Research Institute, Lipoprotein and Atherosclerosis Unit, Prahran, Australia.

Studies of the structure and function of apolipoprotein A-I (apoA-I) often require its purification by delipidation of high density lipoprotein isolated from large quantities of human plasma and separation of apoA-I from other plasma apolipoproteins. To reduce the need for extensive purification procedures, we have developed an insect cell/baculovirus expression system for the production and secretion of human proapoA-I. The recombinant baculovirus containing full-length human apoA-I cDNA, when introduced into Spodoptera frugiperda, directs the synthesis of preproapoA-I, which is subsequently secreted into the growth medium as proapoA-I, indicating correct processing of the signal peptide during secretion. To prevent the extensive degradation of secreted proapoA-I, leupeptin and pepstatin A were added to the serum free cell culture medium. The protein was simply purified by filtration of the medium, which contained up to 80 mg/l proapoA-I, followed by chromatography on phenyl-sepharose CL-4B. The resultant proapoA-I was found to bind lipid and to activate lecithin:cholesterol acyltransferase as effectively as apoA-I from human plasma. The advantage of this expression system is the ease of purification of intact, biologically active apoA-I in high yield.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Kockx, K.-A. Rye, K. Gaus, C. M. Quinn, J. Wright, T. Sloane, D. Sviridov, Y. Fu, D. Sullivan, J. R. Burnett, et al. Apolipoprotein A-I-stimulated Apolipoprotein E Secretion from Human Macrophages Is Independent of Cholesterol Efflux J. Biol. Chem., June 18, 2004; 279(25): 25966 - 25977. [Abstract] [Full Text] [PDF]

				K.-i. Okuhira, M. Tsujita, Y. Yamauchi, S. Abe-Dohmae, K. Kato, T. Handa, and S. Yokoyama Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL J. Lipid Res., April 1, 2004; 45(4): 645 - 652. [Abstract] [Full Text] [PDF]

				H.-h. Li, M. J. Thomas, W. Pan, E. Alexander, M. Samuel, and M. G. Sorci-Thomas Preparation and incorporation of probe-labeled apoA-I for fluorescence resonance energy transfer studies of rHDL J. Lipid Res., December 1, 2001; 42(12): 2084 - 2091. [Abstract] [Full Text] [PDF]

				D. Sviridov, L. E. Pyle, M. Jauhiainen, C. Ehnholm, and N. H. Fidge Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of pre{beta}-high density lipoprotein to {alpha}-high density lipoprotein J. Lipid Res., November 1, 2000; 41(11): 1872 - 1882. [Abstract] [Full Text]

				M. G. Sorci-Thomas, L. Curtiss, J. S. Parks, M. J. Thomas, and M. W. Kearns Alteration in Apolipoprotein A-I 22-Mer Repeat Order Results in a Decrease in Lecithin:Cholesterol Acyltransferase Reactivity J. Biol. Chem., March 14, 1997; 272(11): 7278 - 7284. [Abstract] [Full Text] [PDF]